Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients

Recruiting

Phase 2

Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese PatientsPharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients

Sponsor:

UCLA

Code:

NCT04721873

Conditions

Colitis, Ulcerative

Obesity

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Phentermine-Topiramate

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by University of California, San Diego on 2023-05-16.